PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.760
+0.030 (0.63%)
At close: May 19, 2026, 4:00 PM EDT
4.770
+0.010 (0.21%)
After-hours: May 19, 2026, 7:42 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $90.84 million as of May 19, 2026. Its market cap has increased by 218.34% in one year.
Market Cap
90.84M
Enterprise Value
82.27M
1-Year Change
218.34%
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $90.84M, an increase of 10.19%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 90.84M | 25.82% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 96.51M |
| Seer, Inc. | 95.35M |
| Aardvark Therapeutics | 95.12M |
| LeonaBio | 94.50M |
| ProMIS Neurosciences | 93.58M |
| Oncolytics Biotech | 92.91M |
| Anixa Biosciences | 92.54M |
| Biomea Fusion | 90.37M |